Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Arthropod-borne flaviviruses and RNA interference: seeking new approaches for antiviral therapy.

Diosa-Toro M, Urcuqui-Inchima S, Smit JM.

Adv Virus Res. 2013;85:91-111. doi: 10.1016/B978-0-12-408116-1.00004-5. Review.

PMID:
23439025
2.

Flavivirus RNAi suppression: decoding non-coding RNA.

Pijlman GP.

Curr Opin Virol. 2014 Aug;7:55-60. doi: 10.1016/j.coviro.2014.04.002. Epub 2014 May 8. Review.

PMID:
24793201
3.

Nucleic acid-based inhibition of flavivirus infections.

Stein DA, Shi PY.

Front Biosci. 2008 Jan 1;13:1385-95. Review.

PMID:
17981637
4.

Rapid identification of vector-borne flaviviruses by mass spectrometry.

Grant-Klein RJ, Baldwin CD, Turell MJ, Rossi CA, Li F, Lovari R, Crowder CD, Matthews HE, Rounds MA, Eshoo MW, Blyn LB, Ecker DJ, Sampath R, Whitehouse CA.

Mol Cell Probes. 2010 Aug;24(4):219-28. doi: 10.1016/j.mcp.2010.04.003. Epub 2010 Apr 20.

PMID:
20412852
6.

Viral Interference and Persistence in Mosquito-Borne Flaviviruses.

Salas-Benito JS, De Nova-Ocampo M.

J Immunol Res. 2015;2015:873404. doi: 10.1155/2015/873404. Epub 2015 Oct 25. Review.

7.

[Flavivirus encephalitis].

Takasaki T.

Brain Nerve. 2009 Feb;61(2):145-51. Review. Japanese.

PMID:
19235464
8.

Mouse and hamster models for the study of therapy against flavivirus infections.

Charlier N, De Clercq E, Neyts J.

Novartis Found Symp. 2006;277:218-29; discussion 229-32, 251-3. Review.

PMID:
17319165
9.

Novel flaviviruses from mosquitoes: mosquito-specific evolutionary lineages within the phylogenetic group of mosquito-borne flaviviruses.

Huhtamo E, Cook S, Moureau G, Uzc√°tegui NY, Sironen T, Kuivanen S, Putkuri N, Kurkela S, Harbach RE, Firth AE, Vapalahti O, Gould EA, de Lamballerie X.

Virology. 2014 Sep;464-465:320-9. doi: 10.1016/j.virol.2014.07.015. Epub 2014 Aug 9.

10.

Origins, evolution, and vector/host coadaptations within the genus Flavivirus.

Gould EA, de Lamballerie X, Zanotto PM, Holmes EC.

Adv Virus Res. 2003;59:277-314. Review.

PMID:
14696332
11.
12.

Recent advances in flavivirus antiviral drug discovery and vaccine development.

Ray D, Shi PY.

Recent Pat Antiinfect Drug Discov. 2006 Jan;1(1):45-55. Review.

PMID:
18221133
13.

Advances in flavivirus vaccine development.

Coller BA, Clements DE, Martyak T, Yelmene M, Thorne M, Parks DE.

IDrugs. 2010 Dec;13(12):880-4. Review.

PMID:
21154147
15.

[New approaches to the treatment of the flavivirus infections].

Morozova OV, Isaeva EI, Viazov SO.

Vopr Virusol. 2015;60(6):5-9. Review. Russian.

PMID:
27024909
16.

Genome-wide RNAi screen identifies broadly-acting host factors that inhibit arbovirus infection.

Yasunaga A, Hanna SL, Li J, Cho H, Rose PP, Spiridigliozzi A, Gold B, Diamond MS, Cherry S.

PLoS Pathog. 2014 Feb 13;10(2):e1003914. doi: 10.1371/journal.ppat.1003914. eCollection 2014 Feb.

17.

The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Bardina SV, Lim JK.

Immunol Res. 2012 Dec;54(1-3):121-32. doi: 10.1007/s12026-012-8333-3. Review.

PMID:
22547394
18.

Rodent models for the study of therapy against flavivirus infections.

Charlier N, Leyssen P, De Clercq E, Neyts J.

Antiviral Res. 2004 Aug;63(2):67-77. Review.

PMID:
15321702
20.

Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.

Pastorino B, Nougairède A, Wurtz N, Gould E, de Lamballerie X.

Antiviral Res. 2010 Sep;87(3):281-94. doi: 10.1016/j.antiviral.2010.04.014. Epub 2010 May 7. Review.

PMID:
20452379

Supplemental Content

Support Center